Cargando…

Mechanism by which antibodies to non-AgB antigens mediate rejection of rat leukaemia cells.

The August and Hooded rat strains are compatible at the major histocompatibility locus (both are AgB5 or Rtlc). Antisera against the minor histocompatibility antigens of Hooded rats were raised by immunizing August rats with grafts of tumours or normal tissue. Such antisera, if transferred to normal...

Descripción completa

Detalles Bibliográficos
Autores principales: Denham, S., Hooton, J. W., Barfoot, R. K., Alexander, P., Mayol, R., Wrathmell, A. B.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1980
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010402/
https://www.ncbi.nlm.nih.gov/pubmed/7426344
_version_ 1782136315070906368
author Denham, S.
Hooton, J. W.
Barfoot, R. K.
Alexander, P.
Mayol, R.
Wrathmell, A. B.
author_facet Denham, S.
Hooton, J. W.
Barfoot, R. K.
Alexander, P.
Mayol, R.
Wrathmell, A. B.
author_sort Denham, S.
collection PubMed
description The August and Hooded rat strains are compatible at the major histocompatibility locus (both are AgB5 or Rtlc). Antisera against the minor histocompatibility antigens of Hooded rats were raised by immunizing August rats with grafts of tumours or normal tissue. Such antisera, if transferred to normal unimmunized August rats, cause them to reject i.v. administered Hooded rat leukemia (HRL) cells within a few hours, and X-irradiated August rats, for whom a graft of HRL is lethal, can survive indefinitely if pretreated with the antiserum. The distribution of 125I-labelled HRL cells in the tissues of August rats was followed at times after their injection, and it was found that, in the presence of antiserum, i.v. administered leukaemic cells are rapidly destroyed in the liver and spleen. The active component of the antiserum is IgG antibody, and its action is independent of the lytic elements of complement. Antibody-mediated splenic and hepatic clearance of the leukaemia cells is unaffected by total-body X-irradiation but reduced by treating the rats with colloidal carbon. The data are consistent with the hypothesis that the rejection of HRL across the histocompatibility barrier studied is, in the presence of antibody, effected by immunophagocytosis.
format Text
id pubmed-2010402
institution National Center for Biotechnology Information
language English
publishDate 1980
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20104022009-09-10 Mechanism by which antibodies to non-AgB antigens mediate rejection of rat leukaemia cells. Denham, S. Hooton, J. W. Barfoot, R. K. Alexander, P. Mayol, R. Wrathmell, A. B. Br J Cancer Research Article The August and Hooded rat strains are compatible at the major histocompatibility locus (both are AgB5 or Rtlc). Antisera against the minor histocompatibility antigens of Hooded rats were raised by immunizing August rats with grafts of tumours or normal tissue. Such antisera, if transferred to normal unimmunized August rats, cause them to reject i.v. administered Hooded rat leukemia (HRL) cells within a few hours, and X-irradiated August rats, for whom a graft of HRL is lethal, can survive indefinitely if pretreated with the antiserum. The distribution of 125I-labelled HRL cells in the tissues of August rats was followed at times after their injection, and it was found that, in the presence of antiserum, i.v. administered leukaemic cells are rapidly destroyed in the liver and spleen. The active component of the antiserum is IgG antibody, and its action is independent of the lytic elements of complement. Antibody-mediated splenic and hepatic clearance of the leukaemia cells is unaffected by total-body X-irradiation but reduced by treating the rats with colloidal carbon. The data are consistent with the hypothesis that the rejection of HRL across the histocompatibility barrier studied is, in the presence of antibody, effected by immunophagocytosis. Nature Publishing Group 1980-09 /pmc/articles/PMC2010402/ /pubmed/7426344 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Denham, S.
Hooton, J. W.
Barfoot, R. K.
Alexander, P.
Mayol, R.
Wrathmell, A. B.
Mechanism by which antibodies to non-AgB antigens mediate rejection of rat leukaemia cells.
title Mechanism by which antibodies to non-AgB antigens mediate rejection of rat leukaemia cells.
title_full Mechanism by which antibodies to non-AgB antigens mediate rejection of rat leukaemia cells.
title_fullStr Mechanism by which antibodies to non-AgB antigens mediate rejection of rat leukaemia cells.
title_full_unstemmed Mechanism by which antibodies to non-AgB antigens mediate rejection of rat leukaemia cells.
title_short Mechanism by which antibodies to non-AgB antigens mediate rejection of rat leukaemia cells.
title_sort mechanism by which antibodies to non-agb antigens mediate rejection of rat leukaemia cells.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010402/
https://www.ncbi.nlm.nih.gov/pubmed/7426344
work_keys_str_mv AT denhams mechanismbywhichantibodiestononagbantigensmediaterejectionofratleukaemiacells
AT hootonjw mechanismbywhichantibodiestononagbantigensmediaterejectionofratleukaemiacells
AT barfootrk mechanismbywhichantibodiestononagbantigensmediaterejectionofratleukaemiacells
AT alexanderp mechanismbywhichantibodiestononagbantigensmediaterejectionofratleukaemiacells
AT mayolr mechanismbywhichantibodiestononagbantigensmediaterejectionofratleukaemiacells
AT wrathmellab mechanismbywhichantibodiestononagbantigensmediaterejectionofratleukaemiacells